Selected readings

2020

Mulinari, S, Davis, C, Ozieranski, P. “Failure of Responsive Regulation? Pharmaceutical Marketing, Corporate Impression Management and Off-Label Promotion of Enzalutamide in Europe”. J. White Collar Corp. Crime 2020:2631309X2097047. SagePub External link

Ozieranski, P, Csanádi, M, Rickard, E, Mulinari, S. “Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)”. BMJ Open 2020; 10(9):e037351. BMJ External link

Mulinari, S, Vilhelmsson, A, Rickard, E, Ozieranski, P. “Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs”. PLoS One 2020; 15(6):e0235021. PLoS External link

2019

Cohen, D, Mulinari, S, Ozieranski, P. “The whistleblowing drama behind Astellas’s suspension from the ABPI”. BMJ 2019:l4353. BMJ External link

Ozieranski, P, Csanadi, M, Rickard, E, Tchilingirian, J, Mulinari, S. “Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015”. JAMA Netw. Open 2019; 2(6):e196253. JAMA External link

Ozieranski, P, Rickard, E, Mulinari, S. “Exposing drug industry funding of UK patient organisations”. BMJ 2019:l1806. BMJ External link

Rickard, E, Ozieranski, P, Mulinari, S. “Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK”. Health Policy (New. York). 2019; 123(12):1244–1250. Elsevier External link

2018

Fabbri, A, Santos, A, Mezinska, S, Mulinari, S, Mintzes, B. “Sunshine policies and murky shadows in Europe: Disclosure of pharmaceutical industry payments to health professionals in nine European countries”. Int. J. Heal. Policy Manag. 2018. IJHPM External link

Mulinari, S, Ozieranski, P. “Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: Analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts”. BMJ Open 2018. BMJ External link

2016

Dunn, A, Coiera, E, Mandl, K, Bourgeois, F. “Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency”. Res. Integr. Peer Rev. 2016. RIPR External link